(Q33184380)

English

Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate

scientific article

Statements

Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate (English)
115-21; discussion 122

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit